Atrial fibrillation Trials in Toruń, Poland
Conditions / Atrial fibrillation / Toruń, Poland
Clinical trials for Atrial fibrillation investigate a range of treatment strategies and patient populations.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00580216 | Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation | TERMINATED | PHASE3 |
| NCT01522651 | Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation | COMPLETED | PHASE2 |
| NCT02072434 | Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF) | COMPLETED | PHASE3 |
| NCT04396418 | Stroke Prevention and Rhythm Control Therapy STEEER-AF | ACTIVE_NOT_RECRUITING | NA |
| NCT00403767 | An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT00781391 | Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT00035451 | Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation. | COMPLETED | PHASE3 |
| NCT01830543 | A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention | COMPLETED | PHASE3 |
| NCT00412984 | Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT00938730 | A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation | COMPLETED | PHASE2 |